Antimicrobial Therapy and COVID-19 — the 'Great Confrontation'

Author:

Zaytsev A. A.1ORCID,Makarevich A. М.2

Affiliation:

1. Main Military Clinical Hospital named after academician N. N. Burdenko of the Ministry of Defense of the Russian Federation; Moscow State University of Food Production — Medical Institute of Continuous Education

2. 301st Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Abstract

The problem of antimicrobial therapy (AMT) for the new coronavirus infection has been the cornerstone of practical healthcare since its emergence to the present day. The article summarizes a number of problems concerning the unjustified prescription of AMT based on the data of foreign and domestic studies, as well as actual clinical practice. On the one hand, viral damage to the lung tissue during COVID-19 is difficult to distinguish from community-acquired or secondary bacterial pneumonia; it prompts clinicians to prevent possible bacterial complications in the lungs by prescribing broad-spectrum antibiotics starting from the first day. On the other hand, the presence of clear clinical and biological markers of bacterial pneumonia; and COVID-19 makes it possible not to use antibiotics in routine practice, at least in the early stages of treatment. The introduction of procalcitonin as a biomarker of bacterial infection in COVID-19 into everyday clinical practice has a reasonable, methodical, and scientific approach to prescribing antibiotics.

Publisher

Publishing House OKI

Subject

Infectious Diseases,Microbiology (medical),General Medicine,Microbiology

Reference29 articles.

1. Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Versiya 15 (22.02.2022). Dostupno po: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/VMR_COVID-19_V15.pdf. Ssylka aktivna na 10.07.2022. [Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Versiya 15 (22.02.2022). Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/VMR_COVID-19_V15.pdf. Accessed: July 10, 2022. (in Russian)]

2. Zaitsev A.A., Chernov S.A., Kryukov E.V., Golukhova E.Z., Rybka M.M. Prakticheskii opyt vedeniya patsientov s novoi koronavirusnoi infektsiei COVID-19 v statsionare (predvaritel'nye itogi i rekomendatsii). Lechashchii vrach. 2020; 6: 74–79. [Zaytsev A.A., Chernov S.A., Kryukov E.V., Golukhova E.S., Rybka M.M. Practical experience of managing patients with novel coronavirus infection COVID-19 in hospital (preliminary results and guidelines). Lechashchiy Vrach Journal. 2020; 6: 74–79 (in Russian)]

3. Zaitsev, A. A. Pis'mo v redaktsiyu. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2020; 22 (2): 84–86. https://doi.org/10.36488/cmac.2020.2.84-86. [Zaytsev A.A. Letter to editors. Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22 (2): 84–86 (in Russian)]

4. Zaitsev A.A., Chernov S.A., Stets V.V. i dr. Algoritmy vedeniya patsientov s novoi koronavirusnoi infektsiei COVID-19 v statsionare. Metodicheskie rekomendatsii. Consilium Medicum. 2020; 22 (11): https://doi.org/10.26442/20751753.2020.11.200520. [Zaitsev A.A., Chernov S.A., Stets V.V. et al. Algorithms for the management of patients with a new coronavirus COVID-19 infection in a hospital. Guidelines. Consilium Medicum. 2020; 22 (11): https://doi.org/10.26442/20751753.2020.11.200520. (in Russian)]

5. Griffin D.O., Brennan-Rieder D., Ngo B. et. al. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021 Feb 8; 23 (1): 40–47. doi: 10.24875/AIDSRev.200001261.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3